Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: The Road Ahead for cT2N0M0 Esophageal Adenocarcinoma

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Shapiro J, Van Lanschot JJB, Hulshof MC, van Hagen P, van Berge Henegouwen MI, Wijnhoven BP, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090–8.

    Article  PubMed  Google Scholar 

  2. Rodriguez Quintero JH, Kamel MK, Jindani R, et al. The effect of neoadjuvant therapy on esophagectomy for cT2N0M0 esophageal adenocarcinoma. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14441-z.

    Article  PubMed  Google Scholar 

  3. Stiles BM, Mirza F, Coppolino A, Port JL, Lee PC, Paul S, et al. Clinical T2–T3N0M0 esophageal cancer: the risk of node positive disease. Ann Thorac Surg. 2011;92:491–8. https://doi.org/10.1016/j.athoracsur.2011.04.004.

    Article  PubMed  Google Scholar 

  4. Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med. 2021;384:1191–203. https://doi.org/10.1056/NEJMoa2032125.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This research did not receive financial support from any source.

Author information

Authors and Affiliations

  1. Department of Cardiovascular and Thoracic Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA

    Jorge Humberto Rodriguez-Quintero MD & Brendon M. Stiles MD

Authors
  1. Jorge Humberto Rodriguez-Quintero MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brendon M. Stiles MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brendon M. Stiles MD.

Ethics declarations

Disclosures

Dr. Stiles: Medtronic, AstraZeneca, Genentech, Pfizer, Arcus Biosciences, Bristol Myers Squib, BMS Foundation, Gala Therapeutics, Merck, and the Lung Cancer Research Foundation. The other author has no conflicts of interest to disclose.

Ethical Approval

This research was performed by the 1964 Helsinki Declaration and its later amendments and was approved by an institutional review board. This work has not been published elsewhere.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rodriguez-Quintero, J.H., Stiles, B.M. ASO Author Reflections: The Road Ahead for cT2N0M0 Esophageal Adenocarcinoma. Ann Surg Oncol 31, 892–893 (2024). https://doi.org/10.1245/s10434-023-14467-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14467-3

Search

Navigation